Position in AKBA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$641,162
New position
Shares Held
562,423
first reported quarter
Ownership
0.203%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $10,662,030 across 14 Drug Manufacturers - Specialty & Generic names. AKBA ranks #8 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
184,502 | $1,721,403 | |
| 2 | ALKS |
Alkermes plc.
|
25,815 | $1,352,576 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
35,789 | $1,212,531 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
47,850 | $1,177,588 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
17,744 | $838,758 | |
| 6 | ZTS |
Zoetis Inc.
|
11,360 | $816,329 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
41,957 | $672,570 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
This page
|
562,423 | $641,162 |
All Filings in AKBA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $641,162 | 562,423 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||